Taking Back Healthcare
Read about the future of healthcare - best practices, the latest tech, and more.


Announcements
Athelas Home Expands AI Diagnostics to the Point of Care with FDA Clearance
Athelas, a Commure company, today announced that the FDA cleared the CLIA-waived Athelas Home diagnostic device for use in point-of-care settings. The AI-powered hematology analyzer is used by tens of thousands of patients and now enables same-visit testing to support clinical decisions without reliance on central labs.
February 12, 2026
.avif)